In-home COPD management program cuts 30-day acute-care readmissions
By
Alicia Lasek (f3)
Jun 29, 2022
Thirty-day readmission rates were 12% for post-acute COPD participants in an at-home pulmonary rehab program, and 22% for those without the intervention, a new study finds.
Clinical briefs for Wednesday, June 29
By
Alicia Lasek (f3)
Jun 29, 2022
HHS aims to strengthen primary care, seeks public input … Research focuses on diagnosing, lessening effects of Alzheimer’s disease … Mediterranean diet reduced frailty over 11 years, study finds...
CMS: Phase 3 final guidance imminent, ‘a lot coming’
By
James M. Berklan
Jun 29, 2022
NEW ORLEANS — Nursing home operators can expect long-awaited final guidance on Phase 3 Requirements of Participation “very, very soon,” the federal government’s top skilled nursing official said...
Court ruling expanding range for COVID-19 lawsuits should worry long-term care providers: expert
By
Danielle Brown
Jun 29, 2022
In a first-of-its-kind ruling in the nation, a California Court of Appeals has allowed the wrongful death suit to move forward. This has sparked widespread concern from businesses about the threat of “take-home”...
MDS coordinator strain hits nursing facilities where it hurts most
By
Kimberly Marselas
Jun 29, 2022
Labor shortages are costing providers deeply, but new data finds workforce issues are also impeding their ability to collect payment for services they’ve already delivered.
COVID antiviral study raises red flag for mental status changes in nursing home residents
By
Alicia Lasek (f3)
Jun 28, 2022
Nursing home residents who took COVID antiviral pills had a low hospitalization rate, but some experienced mental status changes while taking Paxlovid, a unique call center study has found.
Spirituality predicted improved resident wellbeing during pandemic isolation: study
By
Alicia Lasek (f3)
Jun 28, 2022
Strong spirituality may have protected residents of extended care facilities from psychological strain when facing social restrictions during the pandemic, investigators report.
Lack of clinical use prompts Biogen to halt real-world Aduhelm drug trial
By
Alicia Lasek (f3)
Jun 28, 2022
The pharmaceutical firm Biogen has stopped a real-world clinical trial for its federally approved Alzheimer’s disease drug aducanumab (Aduhelm).
Clinical briefs for Tuesday, June 28
By
Alicia Lasek (f3)
Jun 28, 2022
CNA candidates “giving up” as exam openings fail to keep pace with worker demand … Feds estimate 91% of all nursing home staff received required COVID-19 vaccine … … Low rate of test result...
Audit finds nearly one-quarter of nursing homes got vaccine exemptions in this region
By
Danielle Brown
Jun 28, 2022
More than 90% of nursing home workers received their required COVID-19 vaccine doses following the implementation of a federal mandate, according to an estimate by the Office of Inspector General.